Scand J Gastroenterol. The prevalence and predictors of elevated serum aminotransferase activity in the United States in — Am J Gastroenterol. ACG clinical guideline: evaluation of abnormal liver chemistries. Diagnosis and monitoring of hepatic injury.
Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem. Dufour DR. Effects of habitual exercise on routine laboratory tests. Green RM, Flamm S. AGA technical review on the evaluation of liver chemistry tests. Evaluation of abnormal liver-enzyme results in asymptomatic patients.
N Engl J Med. Abnormal findings on liver function tests. Interpreting results to narrow the diagnosis and establish a prognosis. Postgrad Med. Evaluation of blood donors with elevated serum alanine aminotransferase levels. Ann Intern Med. The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients. Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients.
Nonalcoholic steatohepatitis: what we know in the new millennium. Aragon G, Younossi ZM. When and how to evaluate mildly elevated liver enzymes in apparently healthy patients. Cleve Clin J Med. Liver diseases. The washington manual of medical therapeutics. Verslype C. Acta Clin Belg. Das A, Post AB. Should liver biopsy be done in asymptomatic patients with chronically elevated transaminases: A costutility analysis.
An assessment of the role of liver biopsies in asymptomatic patients with chronic liver test abnormalities. Dig Dis Sci. Joint effects of body weight and alcohol on elevated serum alanine aminotransferase in the United States population. Clin Gastroenterol Hepatol. Alter HJ. To C or not to C: these are the questions.
Everhart JE. Digestive diseases in the United States: Epidemiology and impact. Maryland: NIH Publication; Dancygier H, Rogart JN. Approach to the patient with abnormal liver enzymes. In: Dancygier H, editor. Clinical hepatology. Verlag Berlin Heidelberg: Springer; Occult hepatitis B virus in liver tissue of individuals without hepatic disease. J Hepatol. New perspectives in the diagnosis of hepatitis C. Semin Liver Dis.
J Clin Microbiol. Liver enzyme alteration: a guide for clinicians. Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis. Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease. Arch Intern Med. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease.
Nonalcoholic steatohepatitis: an expanded clinical entity. Brunt EM. Nonalcoholic steatohepatitis. Alcohollike liver disease in nonalcoholics.
A clinical and histologic comparison with alcohol-induced liver injury. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values.
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Nonalcoholic steatohepatitis in obesity: a reversible condition. Acta Med Scand. Lavine JE. Treatment of obesity-induced steatohepatitis with vitamin E.
Diagnosis of hemochromatosis. American College of Gastroenterology. American Gastroenterological Association Diagnosis and management of hemochromatosis.
Noninvasive prediction of fibrosis in CY homozygous hemochromatosis. Liver inflammation due to alcohol consumption is called alcoholic hepatitis. When drugs are the underlying cause, doctors call it toxic hepatitis. The symptoms of alcoholic and toxic hepatitis are similar to those of other strains of hepatitis. If a person is experiencing symptoms of alcohol or drug use disorder, the doctor may check their liver enzyme levels and offer various forms of treatment and support.
Cirrhosis is a type of liver damage. A person with cirrhosis has permanent scarring of the liver, which can prevent it from working properly. Cirrhosis may eventually lead to liver failure. Cirrhosis symptoms include fatigue and skin itching. People are at risk of cirrhosis if they do not receive treatment for hepatitis or fatty liver disease. A blood test can show elevated liver enzymes.
The blood test checks for raised levels of AST and ALT, which are enzymes that the liver releases when it becomes inflamed or damaged. If a doctor finds that a person has raised AST or ALT levels, they are likely to carry out further tests to determine the underlying cause.
The treatment for elevated liver enzymes will focus on managing the underlying condition causing the increased levels. The doctor may advise a person to make lifestyle changes to lose weight, such as:. Speaking with a nutritionist or even a personal trainer can help someone stay on track with their weight loss plan. If a person has fatty liver disease due to alcohol consumption, the doctor will support them in reducing their alcohol intake.
Treatments for hepatitis depend on whether it is acute or long term. A doctor may recommend the following treatments for acute hepatitis:. This content does not have an Arabic version. Overview Liver function tests are blood tests used to help diagnose and monitor liver disease or damage. Request an Appointment at Mayo Clinic. Share on: Facebook Twitter. Show references Diagnosing liver disease: Liver biopsy and liver function tests.
American Liver Foundation. Accessed April 12, Laboratory tests of the liver and gallbladder. Merck Manual Professional Version.
Friedman LS. Approach to the patient with abnormal liver biochemical and function tests. Blood tests. It is then stored in cells for future use.
Most will be stored in the liver. The leftover amount will be warehoused in the:. Aspartate aminotransferase AST is found in a variety of tissues, including the liver, brain, pancreas , heart, kidneys , lungs, and skeletal muscles. If any of these tissues are damaged, AST will be released into the bloodstream. While increased AST levels are signs of a tissue injury, it doesn't always relate to the liver. By contrast, alanine aminotransferase ALT is found mainly in the liver. If your ALT level is high, this may be a sign of a liver injury.
It could be minor or severe. Occasional increases in ALT may occur when you have a short-term infection or illness. Sustained increases are more serious. That's because this may mean there's an underlying disease and a greater chance of liver damage. The normal levels vary based on a person's body mass index BMI It also depends on the lab's reference value, or typical results. Generally speaking, the normal reference value for adults is:. The high end of the reference range is referred to as the upper limit of normal ULN.
This number is used to establish how elevated your liver enzymes are. Mild elevations are generally considered to be two to three times the ULN. With some liver diseases, the level can be more than 50 times the ULN. Levels this high are described as deranged.
While it may seem that a high ALT is all that is needed to diagnose liver disease, its relationship to AST can provide valuable clues as to what exactly is going on. It will also tell you whether the issue is acute occurring suddenly and progressing rapidly or chronic long-standing or persistent.
If the liver experiences an acute injury, you can expect to see a sudden spike in the ALT. On the other hand, if liver disease is slowly progressing, the damage in the liver will gradually affect other organs too. As these organs are damaged, the AST will begin to rise. This occurs with diseases like hepatitis C. It causes long-term liver damage that triggers symptoms involving:.
These are referred to as extra-hepatic symptoms. Depending on which value is elevated and the amount of elevation, doctors can often get a pretty strong indication as to what disease is involved.
0コメント